Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model

BACKGROUND: Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with increase in the production of VEGF and therefore additional VEGF may not be benefici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Roguin, Ariel, Nitecki, Samy, Rubinstein, Irit, Nevo, Eviatar, Avivi, Aaron, Levy, Nina S, Abassi, Zaid A, Sabo, Edmond, Lache, Orit, Frank, Meira, Hoffman, Aaron, Levy, Andrew P
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2003
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC320491/
https://ncbi.nlm.nih.gov/pubmed/14683529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-2-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados